BP000219-CYT-356: Recombinant Ovine Leptin Antagonist Triple Mutant
Source: E. coli-derived.
ProSpec? Leptin-Antagonist Triple Mutant Ovine Recombinant is capable of inhibiting leptin-induced proliferation of BAF/3 cells stably transfected with the long form of mouse leptin receptor. It also inhibits various leptin effects in several in vitro bioassays.
Purity > 98%, by SDS-PAGE and RP-HPLC.BP000221-CYT-352: Recombinant Human Leptin Antagonist Triple Mutant
Source: E. Coli-derived.
Purity > 98.0% by Gel filtration analysis and SDS-PAGE.BP000221-CYT-353: Recombinant Human Leptin Antagonist Quadruple Mutant
Source: E. Coli-derived.
ProSpec Leptin Quadruple Antagonist Mutant is capable of inhibiting leptin-induced proliferation of BAF/3 cells stably transected with the long form of human Leptin receptor. It also inhibits various Leptin effects in several in vitro bioassays.
Purity > 98.0% by RP-HPLC and SDS-PAGE.BP000221-CYT-354: Recombinant Mouse Leptin Antagonist Triple Mutant
Source: E. Coli-derived.
Purity > 99.0% as determined by Gel filtration analysis and SDS-PAGE.BP000221-CYT-355: Recombinant Rat Leptin Antagonist Triple Mutant
Source: E. Coli-derived.
ProSpec Leptin Antagonist Triple Mutant Rat Recombinant is capable of inhibiting leptin-induced proliferation of BAF/3 cells stably transfected with the long form of human leptin receptor. It also inhibits various leptin effects in several in vitro bioassays.
Purity > 99.0% as determined by Gel filtration analysis and SDS-PAGE.BP000221-CYT-357: Recombinant Ovine Leptin Antagonist Quadruple Mutant
Source: E. Coli-derived.
ProSpec leptin qA is capable of inhibiting leptin-induced proliferation of BAF/3 cells stably transfected with the long form of ovine leptin receptor. It also inhibits various leptin effects in several in vitro bioassays.
Purity > 98.0% as determined by Gel filtration analysis and SDS-PAGE.BP000221-CYT-351: Recombinant Mouse Leptin (LEP) Protein
Source: E. Coli-derived.
Biological activity of Mouse Leptin is performed in two different mouse obesity models, ob/ob and NZO. Both strains of mice were treated via intraperitoneal injection once daily at a dose of 5 ug Leptin/gram body weight for a period of 14 days. Significant effects on body weight , food consumption, and plasma glucose levels were observed to saline-treated controls.
Purity: > 95.0% by reducing SDS?PAGE and SEC-HPLC.BP000221-CYT-503: Recombinant Porcine Leptin (LEP) Protein
Source: E. Coli-derived.
Biological active as evidenced by inducing proliferation of BAF/3 cells stably transfected with the long form of human leptin receptor.
Purity: > 98.0% by Gel filtration analysis and SDS-PAGE.BP000221-CYT-504: Recombinant Horse Leptin (LEP) Protein
Source: E. Coli-derived.
Biological active as evidenced by inducing proliferation of BAF/3 cells stably transfected with the long form of human leptin receptor.
Purity: > 95.0% by reducing SDS?PAGE and SEC-HPLC.BP000221-CYT-505: Recombinant Chicken Leptin (LEP) Protein
Source: E. Coli-derived.
Biological active as evidenced by inducing proliferation of BAF/3 cells stably transfected with the long form of human leptin receptor. Its activity is however 5-10 fold lower as compared to mammalian leptins.
Purity: > 95.0% by reducing SDS?PAGE and SEC-HPLC.